News

MAGENTIQ EYE Secures Investment for AI Gastroenterology Growth

MAGENTIQ EYE Secures Investment for AI Gastroenterology Growth

MAGENTIQ EYE Secures Series A Funding to Transform Gastroenterology

MAGENTIQ EYE LTD., renowned for its cutting-edge AI-powered decision-support software in gastroenterology, has successfully closed its Series A investment round. This funding, primarily led by aMoon, is poised to accelerate the commercialization of its renowned MAGENTIQ-COLO™ software across various regions.

Significant Advances in AI Technology

The MAGENTIQ-COLO™ software, which has received FDA and CE approvals, is engineered to significantly enhance polyp detection and analysis during colonoscopies. By improving adenoma detection rates, it aims to provide real-time insights that help clinicians make informed decisions during procedures. This innovative tool includes advanced features such as polyp size categorization and type estimation, alongside AI-generated reports that streamline the diagnostic process.

Investment Details and Future Plans

This Series A funding round attracted major players in the investment landscape, including Norgine Ventures BV, Nina Capital, and private investors. The round also saw aMoon's partner, Roy Wiesner, joining the board of directors, contributing valuable strategic insight and extensive experience in the health tech industry.

Dror Zur, Ph.D., the founder and CEO of MAGENTIQ EYE, expressed excitement over the investment. "This is a pivotal moment in our journey as we partner with aMoon. Their support allows us to speed up innovation and expand our reach to more patients and physicians, responding to the burgeoning demand for our technologies," he stated.

Strong Market Interest

Wiesner emphasized the unique position of MAGENTIQ EYE in the market, commenting on its comprehensive features and cost-effective scalability. He noted the growing interest from key strategic partners, underlining their confidence in the solution's potential to improve patient outcomes significantly.

Ongoing Clinical Trials and Development

MAGENTIQ EYE is actively conducting clinical trials targeting specialized diseases in both the lower and upper gastrointestinal tract. These include conditions such as ulcerative colitis and early dysplasia in Barrett's esophagus. The funding will enable them to further develop automated quality indicators for GI procedures, enhancing the overall diagnostic tools in their portfolio.

The company aims to leverage this investment to foster growth not just in the U.S. but also in European markets, establishing new partnerships and expanding existing operations to fulfill the demanding landscape of health technology.

About MAGENTIQ EYE

Founded in 2014, MAGENTIQ EYE is dedicated to revolutionizing colonoscopy procedures with its AI-aided solutions. The company has earned recognition in the gastroenterology community and continually strives to set new standards in the field, performing numerous procedures daily with the aid of its flagship product, MAGENTIQ-COLO™.

About aMoon

aMoon is a prominent health tech and life sciences venture capital firm located in Israel, managing an impressive $1.3 billion in assets. The fund aims to support innovative technologies and scientific breakthroughs that can transform healthcare, partnering with visionary entrepreneurs to advance their missions.

Frequently Asked Questions

1. What is MAGENTIQ EYE known for?

MAGENTIQ EYE is recognized for its AI-powered software that enhances decision-making in gastroenterology, particularly in improving colonoscopy outcomes.

2. Who led the Series A funding for MAGENTIQ EYE?

The Series A funding round was primarily led by aMoon, a major HealthTech investment fund focused on innovative solutions in healthcare.

3. What capabilities does MAGENTIQ-COLO™ offer?

MAGENTIQ-COLO™ provides advanced features for polyp detection, size categorization, and AI-generated reports to improve colonoscopy procedures.

4. Which conditions are targeted through MAGENTIQ EYE's clinical trials?

The clinical trials are focusing on diseases like ulcerative colitis, early dysplasia in Barrett's esophagus, and gastric intestinal metaplasia.

5. How will the funding benefit MAGENTIQ EYE?

The funding will support the development of advanced diagnostic tools and enable the company to expand its commercial growth in various global markets, including the USA and Europe.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

QuickFi Nabs Top Finovate Award for Fourth Time

Updated Category News Views 5

An Unstoppable Force in Fintech Well, if QuickFi hasn't made a name for itself in fintech, then folks, I don't know what to tell you. This year, they’ve snagged yet another prestigious Finovate Award—this time for Best SMB/SME Banking Solution. That's not their first rodeo either; it’s the fourth time they’ve walked away winners. It's almost like they're...

Continue Reading
Modeling and Mental Health Join Forces for Wellness

Updated Category News Views 5

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

Continue Reading
Streamlined AI Video Analytics for Public Safety Unveiled

Updated Category News Views 3

AI Without the Headache Alright folks, IREX is shaking things up, and not in the usual iterative, bit-by-bit tech progression way. StreamVLM™ has been rolled out as the world's first vision-language model (VLM) analytics engine tailored for the public safety sector—specifically, for cloud platforms. I’ve been around the block enough times to spot a significant shift...

Continue Reading
Lick the Plate Hits 2,000 Shows with Clown Band

Updated Category News Views 5

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Continue Reading
Fermi's Founder Pushes for Board Overhaul: What's Next?

Updated Category News Views 4

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...

Continue Reading
Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 5

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
DCM Services Teams with AKUVO to Boost Estate Recoveries

Updated Category News Views 14

Revolutionizing Estate Recovery Practices Here's the scoop: DCM Services (DCMS), that big shot in estate account resolution, is hooking up with AKUVO to shake up how credit unions handle estate recoveries. This alliance is a clear nod to modernizing a process stuck in the past. Let’s face it, handling decedent and probate accounts is no cakewalk, and traditional methods...

Continue Reading
Sustainability Investments: $17 Trillion Wager Faces Divergence

Updated Category News Views 4

Sustainability Investments: A Tale of Contrasts In the world of sustainability, a staggering $17 trillion has been poured into technologies over the past decade. That’s no chump change. But what do we have to show for it? According to Bain & Company’s latest report, this massive financial injection hasn’t exactly hit a home run. Progress, much like the stock market...

Continue Reading
NYSE Reflects on 9/11: Honoring Lives and Legacy

Updated Category News Views 7

A Somber Day at NYSE: Reflecting on 9/11 September 11th grips the heart of NYSE every year, but this year's 25th-anniversary powerfully reverberates through its hallowed halls. The hustle of the trading floor halts for a moment at 9:20 AM ET, paying homage to those lost in the harrowing attacks. I've seen the markets flap in the wind of countless crises, but nothing's...

Continue Reading
Melissa Rivers Brings Her Wit Back to Emmys Carpet

Updated Category News Views 12

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Crypto Analyst Shares Insights on Top Picks in Emerging Sectors

Updated Category News Views 212

Crypto Analyst Insights on Top Investment Picks Crypto analyst Miles Deutscher has been vocal about his high expectations for Bitcoin and certain altcoins in the near future. His insight may serve as a guide for investors looking to navigate the ever-changing landscape of cryptocurrency. What’s on the Horizon for Bitcoin? In a recent video, Deutscher highlighted...

Continue Reading
Coface Showcases Impressive Growth in 2024 Financials

Updated Category News Views 126

Impressive Financial Results for Coface in 2024 Coface, known for its expertise in trade credit risk management, has reported remarkable financial results for the year 2024. The company's net income stood at €261.1 million, reflecting an 8.6% increase compared to the previous year. This surge is a product of strategic operations that evidently resonated well with the...

Continue Reading
Transforming Commercial Insurance with Epic Quotes in Canada

Updated Category News Views 77

Revolutionizing the Commercial Insurance Quoting Process Applied Systems has made an impressive stride with the launch of Epic Quotes Commercial Lines, a groundbreaking commercial lines rating solution for insurance brokers in Canada. This advancement aims to simplify and enhance the quoting process, allowing brokers to provide better and faster service to their clients....

Continue Reading
Hormel Foods Welcomes Ash Bhumbla as New CFO

Updated Category News Views 11

The Winds of Change Are Blowing at Hormel Foods A major shift is underway at Hormel Foods Corporation, the giant behind brands like SPAM and SKIPPY. They've just tapped Ash Bhumbla to be their new financial captain, stepping into the role of executive vice president and chief financial officer come September 8th. This move kicks off a new chapter for NYSE:HRL under...

Continue Reading
ING Group Enhances Corporate Financing with Risk Transfer Deals

Updated Category News Views 344

ING Group Completes Significant Risk Transfer Transactions ING Group has successfully executed two major risk sharing transactions, marking a unique milestone for ING Wholesale Banking. These transactions signify the first use of risk transfer strategies for the bank, providing first-loss protection on a diverse portfolio of corporate loans totaling €10.5 billion....

Continue Reading